MolecuLight Partners with WoundZoom to Deliver Cloud-Based Wound Management Solution Integrated with its Point-of-Care Bacterial Imaging
National Harbor, MD – April 27, 2023 – MolecuLight Corp., the leader in point-of-care fluorescence imaging that detects and locates elevated bacterial loads in wounds, announced today that the company has partnered with Perceptive Solutions to deliver a cloud-based wound management solution via its WoundZoom® platform that will be integrated with the MolecuLightDX™ point-of-care bacterial imaging device. The new partnership is being announced at the SAWC (Symposium for the Advancement of Wound Care) Spring 2023 conference, April 27 – 29, 2023 being held in National Harbor, MD. Both companies will be exhibiting side-by-side (Perceptive Solutions/WoundZoom at booth #631; MolecuLight at booth #627) and will be demonstrating their respective products, as well as discussing the integrated imaging – wound management solution.
With the integrated solution, wound care clinicians will now be able to benefit from having bacterial imaging and digital wound measurement as well as industry-leading total cloud-based wound management system, including:
- Comprehensive patient/wound documentation and tracking,
- Wound department analytics and dashboarding, and
- Cloud-based synchronization of multiple MolecuLightDX devices.
For customers that are interested in this novel cloud solution, the integration of the MolecuLightDX device with WoundZoom will automate image and measurement uploading, synchronize data across multiple DX devices in a facility, and allow department administrators to focus on continuous improvement of patient care and wound care operations.
“We are thrilled to announce our integration of the MolecuLightDX with WoundZoom to provide an industry-leading solution for cloud-based wound management,” says Anil Amlani, MolecuLight’s CEO. “Our extensive body of clinical evidence reveals how MolecuLight informs clinical descision making, enabling wound care clinicians to achieve improved outcomes. These published results show faster healing rates, reduced costs including reduced use of antibiotics and antimicrobial dressings, and improved patient engagement and involvement in their wound healing efforts. With the integration to WoundZoom, clinicians can further improve efficiencies from comprehensive dashboarding and department-wide analytics, real-time connectivity and synchronization of their multiple MolecuLight devices to the cloud. The potential for improved documentation, operational efficiencies and for tracking patient progress is significant”.
“WoundZoom is providing a new level of efficiency, transparency and centralized decision-making for the wound care clinicians and administrators across all sites of service in the US,” says Mark Lacerte, CEO of Perceptive Solutions. “The ability to now have point-of-care diagnostic imaging provided by the MolecuLightDX device provides a more robust view of a patient’s wounds and allows clinicians to make more informed decisions about wound hygiene and treatment planning. Added to our robust wound management platform, we can now facilitate more comprehensive documentation and reporting of department operational efficiencies, and ultimately, improved patient outcomes.”
The MolecuLight i:X and DX are the only imaging devices for the real-time detection of elevated bacterial burden in wounds that are FDA-cleared, CE-Marked and approved by Health Canada. With clinical evidence including over 75 peer-reviewed publications involving 1,500 patients, the devices are used by leading wound care facilities globally.
For more information, visit https://perceptivesol.com and www.moleculight.com.
